SI
QTTB icon

Sofinnova Investments’s Q32 Bio QTTB Stock Holding History

Sofinnova Investments’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,223
Closed -$2.55M – 82
2020
Q3 		$2.55M Sell
13,223
-5,920
-31% -$1.33M 0.19% 57
2020
Q2 		$5.23M Buy
19,143
+6,328
+49% +$1.69M 0.33% 57
2020
Q1 		$3.58M Buy
12,815
+9,237
+258% +$2.83M 0.33% 41
2019
Q4 		$1.33M Sell
3,578
-4,550
-56% -$1.3M 0.1% 55
2019
Q3 		$2.65M Buy
+8,128
New +$2.76M 0.24% 54

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments's QTTB Position: Q4 2020 in Review

Sofinnova Investments sold out of Q32 Bio (QTTB) in Q4 2020, closing a stake of 13,223 shares — an estimated $2.55M sold.

Sofinnova Investments first reported a position in QTTB in Q3 2019 and held it in 5 quarters. The position peaked at $5.23M in Q2 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q4 2020.

  • Sofinnova Investments reported no remaining Q32 Bio position as of Q4 2020 after selling out during the quarter.
  • Sofinnova Investments sold 13,223 Q32 Bio shares in Q4 2020, an estimated $2.55M.
  • Sofinnova Investments first reported a position in Q32 Bio in Q3 2019 and held it in 5 quarters.
  • Sofinnova Investments's Q32 Bio position peaked at $5.23M in Q2 2020.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2020.

Based on Sofinnova Investments's 13F filing for Q4 2020, filed 16 Feb 2021.